Augmenix To Present at the 35th Annual J.P. Morgan Healthcare Conference

PRESS RELEASE: Augmenix, Inc. a medical technology company that develops, manufactures, and sells proprietary absorbable hydrogels that separate and protect organs at risk during prostate radiotherapy, today announced that it will participate in the...